Core Insights - The article highlights how Beckman Coulter emerged as the leader in the flow cytometer market in the first half of 2025, achieving a total bid amount of 107.44 million yuan, capturing 27.41% of the market share amidst challenging conditions for imported brands [2]. Group 1 - Key Point 1: "Strategic Localization" - Beckman Coulter's flow cytometer bid amount of 52.18 million yuan for flow sorting instruments accounted for a significant portion of its total bid amount, with all models developed and produced at its Suzhou R&D center [4][5][6]. - Key Point 2: Differentiated Strategy Targeting High-End Research Market - Beckman Coulter's lowest bid price exceeded 400,000 yuan, with over 60% of its flow cytometers priced above 1 million yuan, contrasting with the market trend of low-price penetration [8][10]. Group 2 - Key Point 1: Market Composition - In the first half of 2025, hospitals and disease control centers accounted for 67% of flow cytometer bids, while Beckman Coulter's bids were predominantly from universities and research institutions, which made up 85% of its market, indicating a focus on the high-end research segment [10].